Impact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control study. by Rafael Simó, Oleguer Plana-Ripoll, Diana Puente, Rosa Morros, Xavier Mundet, Luz M Vilca, Cristina Hernández, Inmaculada Fuentes, Adriana Procupet, Josep M Tabernero, Concepción Violán

Get full text